// App-Quantinova.ai

528 2015 ATVB : ApoA-I Mimetic Peptide Treatment Improves Left Ventricular Diastolic Dysfunction and Decreases Iron Content in Coronary Plaques in Rabbits

Researchers

Presenter

  • David Busseuil

Principal Investigators

  • Yanfen Shi

  • Teodora Mihalache-Avram

  • Melanie Mecteau

  • Genevieve Brand

  • Gabriel Theberge-Julien

  • Eric Rheaume

  • Jean-Claude Tardif

Medical Centers

  • Montreal Heart Institute, Montreal, Quebec, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Left ventricular diastolic dysfunction

Biomarkers

  • Apolipoprotein A-I

Drug/Treatment

  • Ergocalciferol

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved